Showing results (31-40 of 353) with videos related to
Sort By:
Pageof 36
The Canadian Journal of Urology|April 20, 2010
5A prospective survey of current prostate biopsy practices among oncological urologistsSimon Brewster, Levent Turkeri, Maurizio Brausi, et al.The Canadian Journal of Urology|April 21, 2011
New findings in bladder and prostate cancer: highlights from the 26th annual congress of the European Association of Urology, March 18-22, 2011, Vienna, AustriaAlex Farr, Roman Herout, Markus Margreiter, et al.Current Opinion in Urology|November 20, 2012
Correlation between benign prostatic hyperplasia and inflammationYakup Bostanci, Amir Kazzazi, Shabnam Momtahen, et al.Annals of the New York Academy of Sciences|January 26, 2011
Chemopreventive effects of resveratrol and resveratrol derivativesThomas Szekeres, Philipp Saiko, Monika Fritzer-Szekeres, et al.European Urology|January 1, 2003
PSA progression following radical prostatectomy and radiation therapy: new standards in the new MillenniumBob Djavan, Judd W Moul, Alexandre Zlotta, et al.Current Opinion in Urology|November 30, 2011
American Urological Association and European Association of Urology guidelines in the management of benign prostatic hypertrophy: revisitedArmando A Juliao, Mauricio Plata, Amir Kazzazi, et al.Current Opinion in Urology|November 10, 2012
Imaging in benign prostatic hyperplasia: what is new?Hamidreza Abdi, Amir Kazzazi, Soroush T Bazargani, et al.BJU International|March 30, 2011
The short-term use of erythropoetin-stimulating agents: impact on the biochemical recurrence of prostate cancerBob Djavan, Juliana Laze, Elisabeth Eckersberger, et al.Urologia Internationalis|July 8, 2003
A prospective randomized study of combined visual laser ablation and transurethral resection of the prostate versus transurethral prostatectomy aloneBernhard Planz, Tomislav Kalem, Christian Sprenger, et al.The Canadian Journal of Urology|August 26, 2010
Analysis of testosterone suppression in men receiving histrelin, a novel GnRH agonist for the treatment of prostate cancerBob Djavan, Peter Schlegel, Georg Salomon, et al.Pageof 36